Daniel J Booser

2023

Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer

Nelson, B. E., Saleem, S., Damodaran, S., Somaiah, N., Piha-Paul, S., Moore, J. A., Yilmaz, B., Ogbonna, D., Karp, D. D., Ileana Dumbrava, E., Tsimberidou, A. M., Hong, D. S., Rodon Ahnert, J., Milton, D. R., Zheng, X., Booser, D. J., Ibrahim, N. K., Conley, A. P., Bhosale, P., Rojas Hernandez, C. M., & 3 othersTripathy, D., Naing, A. & Meric-Bernstam, F., 2023, (Accepted/In press) In: Cancer.

Research output: Contribution to journal › Article › peer-review

Short-Term Biomarker Modulation Study of Dasatini for Estrogen Receptor–Negative Breast Cancer Chemoprevention

Mustafayev, F. N. A., Liu, D. D., Gutierrez, A. M., Lewis, J. E., Ibrahim, N. K., Valero, V., Booser, D. J., Litton, J. K., Koenig, K., Yu, D., Sneige, N. & Arun, B. K., Oct 2023, In: European Journal of Breast Health. 19, 4, p. 267-273 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

2019

A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment

Lim, B., Murthy, R. K., Lee, J., Jackson, S. A., Iwase, T., Davis, D. W., Willey, J. S., Wu, J., Shen, Y., Tripathy, D., Alvarez, R., Ibrahim, N. K., Brewster, A. M., Barcenas, C. H., Brown, P. H., Giordano, S. H., Moulder, S. L., Booser, D. J., Moscow, J. A., Piekarz, R., & 2 othersValero, V. & Ueno, N. T., Jun 11 2019, In: British journal of cancer. 120, 12, p. 1105-1112 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

21 Scopus citations

SET_ER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer

Sinn, B. V., Fu, C., Lau, R., Litton, J., Tsai, T. H., Murthy, R., Tam, A., Andreopoulou, E., Gong, Y., Murthy, R., Gould, R., Zhang, Y., King, T. A., Viale, A., Andrade, V., Giri, D., Salgado, R., Laios, I., Sotiriou, C., Marginean, E. C., & 6 othersKwiatkowski, D. N., Layman, R. M., Booser, D., Hatzis, C., Vicente Valero, V. & Fraser Symmans, W., Dec 1 2019, In: npj Breast Cancer. 5, 1, 16.

Research output: Contribution to journal › Article › peer-review

Open Access

43 Scopus citations

2018

A phase II study of imatinib mesylate and letrozole in patients with hormone receptor-positive metastatic breast cancer expressing c-kit or PDGFR-β

Yam, C., Murthy, R. K., Rauch, G. M., Murray, J. L., Walters, R. S., Valero, V., Brewster, A. M., Bast, R. C., Booser, D. J., Giordano, S. H., Esteva, F. J., Yang, W., Hortobagyi, G. N., Moulder, S. L. & Arun, B., Dec 1 2018, In: Investigational New Drugs. 36, 6, p. 1103-1109 7 p.

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

2015

Inhibition of the phosphoinositide 3-kinase pathway for the treatment of patients with metastatic metaplastic breast cancer

Moulder, S., Helgason, T., Janku, F., Wheler, J., Moroney, J., Booser, D., Albarracin, C., Morrow, P. K., Atkins, J., Koenig, K., Gilcrease, M. & Kurzrock, R., Jul 1 2015, In: Annals of Oncology. 26, 7, p. 1346-1352 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

48 Scopus citations

2014

Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2-positive metastatic breast cancer

Murthy, R. K., Varma, A., Mishra, P., Hess, K. R., Young, E., Murray, J. L., Koenig, K. H., Moulder, S. L., Melhem-Bertrandt, A., Giordano, S. H., Booser, D., Valero, V., Hortobagyi, G. N. & Esteva, F. J., Jul 1 2014, In: Cancer. 120, 13, p. 1932-1938 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

37 Scopus citations

Pilot study to assess toxicity and pharmacokinetics of docetaxel in patients with metastatic breast cancer and impaired liver function secondary to hepatic metastases

Eckmann, K., Michaud, L. B., Rivera, E., Madden, T. L., Esparza-Guerra, L., Kawedia, J., Booser, D. J., Green, M. C., Hortobagyi, G. N. & Valero, V., Apr 2014, In: Journal of Oncology Pharmacy Practice. 20, 2, p. 120-129 10 p.

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

2013

Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancer

Dean-Colomb, W., Hess, K. R., Young, E., Gornet, T. G., Handy, B. C., Moulder, S. L., Ibrahim, N., Pusztai, L., Booser, D., Valero, V., Hortobagyi, G. N. & Esteva, F. J., Jan 2013, In: Breast Cancer Research and Treatment. 137, 2, p. 631-636 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

28 Scopus citations

Outcome of metastatic breast cancer in selected women with or without deleterious BRCA mutations

Bayraktar, S., Gutierrez-Barrera, A. M., Lin, H., Elsayegh, N., Tasbas, T., Litton, J. K., Ibrahim, N. K., Morrow, P. K., Green, M., Valero, V., Booser, D. J., Hortobagyi, G. N. & Arun, B. K., Jun 2013, In: Clinical and Experimental Metastasis. 30, 5, p. 631-642 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

26 Scopus citations

Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy

Skinner, H. D., Strom, E. A., Motwani, S. B., Woodward, W. A., Green, M. C., Babiera, G., Booser, D. J., Meric-Bernstam, F. & Buchholz, T. A., Jan 11 2013, In: Radiation Oncology. 8, 1, 13.

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

2012

A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer

Moulder, S., Gladish, G., Ensor, J., Gonzalez-Angulo, A. M., Cristofanilli, M., Murray, J. L., Booser, D., Giordano, S. H., Brewster, A., Moore, J., Rivera, E., Hortobagyi, G. N. & Tran, H. T., May 1 2012, In: Cancer. 118, 9, p. 2378-2384 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

20 Scopus citations

Estrogen Receptor (ER) mRNA and ER-related gene expression in breast cancers that are 1% to 10% ER-positive by immunohistochemistry

Iwamoto, T., Booser, D., Valero, V., Murray, J. L., Koenig, K., Esteva, F. J., Ueno, N. T., Zhang, J., Shi, W., Qi, Y., Matsuoka, J., Yang, E. J., Hortobagyi, G. N., Hatzis, C., Symmans, W. F. & Pusztai, L., Mar 1 2012, In: Journal of Clinical Oncology. 30, 7, p. 729-734 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

217 Scopus citations

Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers

Santarpia, L., Qi, Y., Stemke-Hale, K., Wang, B., Young, E. J., Booser, D. J., Holmes, F. A., O'Shaughnessy, J., Hellerstedt, B., Pippen, J., Vidaurre, T., Gomez, H., Valero, V., Hortobagyi, G. N., Symmans, W. F., Bottai, G., Di Leo, A., Gonzalez-Angulo, A. M. & Pusztai, L., Jul 2012, In: Breast Cancer Research and Treatment. 134, 1, p. 333-343 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

106 Scopus citations

Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer

Kelly, C. M., Green, M. C., Broglio, K., Thomas, E. S., Brewster, A. M., Valero, V., Ibrahim, N. K., Gonzalez-Angulo, A. M., Booser, D. J., Walters, R. S., Hunt, K. K., Hortobagyi, G. N. & Buzdar, A. U., Mar 20 2012, In: Journal of Clinical Oncology. 30, 9, p. 930-935 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

34 Scopus citations

2011

A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer

Hatzis, C., Pusztai, L., Valero, V., Booser, D. J., Esserman, L., Lluch, A., Vidaurre, T., Holmes, F., Souchon, E., Wang, H., Martin, M., Cotrina, J., Gomez, H., Hubbard, R., Chacón, J. I., Ferrer-Lozano, J., Dyer, R., Buxton, M., Gong, Y., Wu, Y., & 10 othersIbrahim, N., Andreopoulou, E., Ueno, N. T., Hunt, K., Yang, W., Nazario, A., DeMichele, A., O'Shaughnessy, J., Hortobagyi, G. N. & Symmans, W. F., May 11 2011, In: JAMA. 305, 18, p. 1873-1881 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

468 Scopus citations

CYP2D6 inhibition and breast cancer recurrence in a population-based study in Denmark

Booser, D. J., 2011, In: Breast Diseases. 22, 3, p. 298-299 2 p.

Research output: Contribution to journal › Comment/debate › peer-review

Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer

Iwamoto, T., Bianchini, G., Booser, D., Qi, Y., Coutant, C., Ya-Hui Shiang, C., Santarpia, L., Matsuoka, J., Hortobagyi, G. N., Symmans, W. F., Holmes, F. A., O'Shaughnessy, J., Hellerstedt, B., Pippen, J., Andre, F., Simon, R. & Pusztai, L., Feb 2 2011, In: Journal of the National Cancer Institute. 103, 3, p. 264-272 9 p.

Research output: Contribution to journal › Article › peer-review

184 Scopus citations

Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy

Morrow, P. K., Wulf, G. M., Ensor, J., Booser, D. J., Moore, J. A., Flores, P. R., Xiong, Y., Zhang, S., Krop, I. E., Winer, E. P., Kindelberger, D. W., Coviello, J., Sahin, A. A., Nuñez, R., Hortobagyi, G. N., Yu, D. & Esteva, F. J., Aug 10 2011, In: Journal of Clinical Oncology. 29, 23, p. 3126-3132 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

191 Scopus citations

Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: Long-term results

Arun, B. K., Dhinghra, K., Valero, V., Kau, S. W., Broglio, K., Booser, D., Guerra, L., Yin, G., Walters, R., Sahin, A., Ibrahim, N., Buzdar, A. U., Frye, D., Sneige, N., Strom, E., Ross, M., Theriault, R. L., Vadhan-Raj, S. & Hortobagyi, G. N., 2011, In: Oncologist. 16, 11, p. 1527-1534 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

23 Scopus citations

Responses to liposomal doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast: Biologic rationale and implications for stem-cell research in breast cancer

Moulder, S., Moroney, J., Helgason, T., Wheler, J., Booser, D., Albarracin, C., Morrow, P. K., Koenig, K. & Kurzrock, R., Jul 1 2011, In: Journal of Clinical Oncology. 29, 19, p. e572-e575

Research output: Contribution to journal › Article › peer-review

61 Scopus citations

2010

A phase 2 study of A fixed combination of uracil and ftorafur (UFT) and leucovorin given orally in A 3-times-daily regimen to treat patients with recurrent metastatic breast cancer

Hortobagyi, G. N., Heim, W., Hutchins, L., Rivera, E., Mason, B., Booser, D. J. & Kirshner, J., Mar 15 2010, In: Cancer. 116, 6, p. 1440-1445 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

6 Scopus citations

Effect of training-sample size and classification difficulty on the accuracy of genomic predictors

Popovici, V., Chen, W., Gallas, B. G., Hatzis, C., Shi, W., Samuelson, F. W., Nikolsky, Y., Tsyganova, M., Ishkin, A., Nikolskaya, T., Hess, K. R., Valero, V., Booser, D., Delorenzi, M., Hortobagyi, G. N., Shi, L., Symmans, W. F. & Pusztai, L., Jan 11 2010, In: Breast Cancer Research. 12, 1, R5.

Research output: Contribution to journal › Article › peer-review

158 Scopus citations

Genomic index of sensitivity to endocrine therapy for breast cancer

Symmans, W. F., Hatzis, C., Sotiriou, C., Andre, F., Peintinger, F., Regitnig, P., Daxenbichler, G., Desmedt, C., Domont, J., Marth, C., Delaloge, S., Bauernhofer, T., Valero, V., Booser, D. J., Hortobagyi, G. N. & Pusztai, L., Sep 20 2010, In: Journal of Clinical Oncology. 28, 27, p. 4111-4119 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

219 Scopus citations

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer: Long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099

Alvarez, R. H., Booser, D. J., Cristofanilli, M., Sahin, A. A., Strom, E. A., Guerra, L., Kau, S. W., Gonzalez-Angulo, A. M., Hortobagyi, G. N. & Valero, V., Mar 1 2010, In: Cancer. 116, 5, p. 1210-1217 8 p.

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

2009

Pilot study of targeted skeletal radiation therapy for bone-only metastatic breast cancer

Ueno, N. T., Souza, J. A. D., Booser, D., Nakayama, K., Madewell, J., Wendt, R. E., Hortobagyi, G. N., Podoloff, D. & Champlin, R. E., 2009, In: Clinical breast cancer. 9, 3, p. 173-177 5 p.

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

2008

Imatinib mesylate (Gleevec®) in advanced breast cancer-expressing C-Kit or PDGFR-β: Clinical activity and biological correlations

Cristofanilli, M., Morandi, P., Krishnamurthy, S., Reuben, J. M., Lee, B. N., Francis, D., Booser, D. J., Green, M. C., Arun, B. K., Pusztai, L., Lopez, A., Islam, R., Valero, V. & Hortobagyi, G. N., 2008, In: Annals of Oncology. 19, 10, p. 1713-1719 7 p.

Research output: Contribution to journal › Article › peer-review

75 Scopus citations

Phase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer

Moulder, S. L., Symmans, W. F., Booser, D. J., Madden, T. L., Lipsanen, C., Yuan, L., Brewster, A. M., Cristofanilli, M., Hunt, K. K., Buchholz, T. A., Zwiebel, J., Valero, V., Hortobagyi, G. N. & Esteva, F. J., Dec 1 2008, In: Clinical Cancer Research. 14, 23, p. 7909-7916 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

56 Scopus citations

Residual risk of breast cancer recurrence 5 years after adjuvant therapy

Brewster, A. M., Hortobagyi, G. N., Broglio, K. R., Kau, S. W., Santa-Maria, C. A., Arun, B., Buzdar, A. U., Booser, D. J., Valero, V., Bondy, M. & Esteva, F. J., Aug 2008, In: Journal of the National Cancer Institute. 100, 16, p. 1179-1183 5 p.

Research output: Contribution to journal › Article › peer-review

Open Access

271 Scopus citations

Using response to primary chemotherapy to select postoperative therapy: Long-term results from a prospective phase II trial in locally advanced primary breast cancer

Gonzalez-Angulo, A. M., Walters, R., Broglio, K., Frye, D., Strom, E., Theriault, R., Booser, D., Valero, V., Buzdar, A. & Hortobagyi, G., Dec 1 2008, In: Clinical breast cancer. 8, 6, p. 516-521 6 p.

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

2007

Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study

Gong, Y., Yan, K., Lin, F., Anderson, K., Sotiriou, C., Andre, F., Holmes, F. A., Valero, V., Booser, D., Pippen, J. E., Vukelja, S., Gomez, H., Mejia, J., Barajas, L. J., Hess, K. R., Sneige, N., Hortobagyi, G. N., Pusztai, L. & Symmans, W. F., Mar 2007, In: Lancet Oncology. 8, 3, p. 203-211 9 p.

Research output: Contribution to journal › Article › peer-review

164 Scopus citations

Phase II trial of 10-EDAM in the treatment of metastatic breast cancer

Beinart, G. A., Gonzalez-Angulo, A. M., Broglio, K., Frye, D., Walters, R., Holmes, F. A., Gunale, S., Booser, D., Rosenthal, J., Dhingra, K., Young, J. A. & Hortobagyi, G. N., Jun 2007, In: Cancer chemotherapy and pharmacology. 60, 1, p. 61-67 7 p.

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

2006

A nonreplicating adenoviral vector that contains the wild-type p53 transgene combined with chemotherapy for primary breast cancer: Safety, efficacy, and biologic activity of a novel gene-therapy approach

Cristofanilli, M., Krishnamurthy, S., Guerra, L., Broglio, K., Arun, B., Booser, D. J., Menander, K., Van Wart Hood, J., Valero, V. & Hortobagyi, G. N., Sep 1 2006, In: Cancer. 107, 5, p. 935-944 10 p.

Research output: Contribution to journal › Article › peer-review

46 Scopus citations

Bortezomib (VELCADE®) in metastatic breast cancer: Pharmacodynamics, biological effects, and prediction of clinical benefits

Yang, C. H., Gonzalez-Angulo, A. M., Reuben, J. M., Booser, D. J., Pusztai, L., Krishnamurthy, S., Esseltine, D., Stec, J., Broglio, K. R., Islam, R., Hortobagyi, G. N. & Cristofanilli, M., May 2006, In: Annals of Oncology. 17, 5, p. 813-817 5 p.

Research output: Contribution to journal › Article › peer-review

122 Scopus citations

Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer

Hess, K. R., Anderson, K., Symmans, W. F., Valero, V., Ibrahim, N., Mejia, J. A., Booser, D., Theriault, R. L., Buzdar, A. U., Dempsey, P. J., Rouzier, R., Sneige, N., Ross, J. S., Vidaurre, T., Gómez, H. L., Hortobagyi, G. N. & Pusztai, L., Sep 10 2006, In: Journal of Clinical Oncology. 24, 26, p. 4236-4244 9 p.

Research output: Contribution to journal › Article › peer-review

595 Scopus citations

Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: Follow-up at 12 years

Hanrahan, E. O., Broglio, K., Frye, D., Buzdar, A. U., Theriault, R. L., Valero, V., Booser, D. J., Singletary, S. E., Strom, E. A., Gajewski, J. L., Champlin, R. E. & Hortobagyi, G. N., Jun 1 2006, In: Cancer. 106, 11, p. 2327-2336 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

28 Scopus citations

2005

Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma

Gong, Y., Booser, D. J. & Sneige, N., May 1 2005, In: Cancer. 103, 9, p. 1763-1769 7 p.

Research output: Contribution to journal › Article › peer-review

146 Scopus citations

Herceptin plus chemotherapy combination in preoperative regimen may offer clinical benefit in early stage breast cancer

Ibrahim, N., Francis, D., Booser, D., Thomas, E., Theriault, R., Pusztai, L., Green, M., Arun, B., Giordano, S., Cristofanilli, M., Frye, D., Smith, T., Hunt, K., Singletary, E., Sahin, A., Ewer, M., Buchholz, T., Berry, D. & Hortobagyi, G., May 2005, In: Cancer Biology and Therapy. 4, 5

Research output: Contribution to journal › Comment/debate › peer-review

Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma

Pusztai, L., Wagner, P., Ibrahim, N., Rivera, E., Theriault, R., Booser, D., Symmans, F. W., Wong, F., Blumenschein, G., Fleming, D. R., Rouzier, R., Boniface, G. & Hortobagyi, G. N., Aug 15 2005, In: Cancer. 104, 4, p. 682-691 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

251 Scopus citations

Phase I trial of dose-dense docetaxel and doxorubicin with or without sargramostim in patients with metastatic breast cancer

Montero, A., Booser, D., Esparza-Guerra, L., Murray, J., Rosales, M., Hortobagyi, G. & Valero, V., 2005, In: Drugs in R and D. 6, 5, p. 299-305 7 p.

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: Results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer

Buzdar, A. U., Ibrahim, N. K., Francis, D., Booser, D. J., Thomas, E. S., Theriault, R. L., Pusztai, L., Green, M. C., Arun, B. K., Giordano, S. H., Cristofanilli, M., Frye, D. K., Smith, T. L., Hunt, K. K., Singletary, S. E., Sahin, A. A., Ewer, M. S., Buchholz, T. A., Berry, D. & Hortobagyi, G. N., 2005, In: Journal of Clinical Oncology. 23, 16, p. 3676-3685 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

1073 Scopus citations

Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks

Green, M. C., Buzdar, A. U., Smith, T., Ibrahim, N. K., Valero, V., Rosales, M. F., Cristofanilli, M., Booser, D. J., Pusztai, L., Rivera, E., Theriault, R. L., Carter, C., Frye, D., Hunt, K. K., Symmans, W. F., Strom, E. A., Sahin, A. A., Sikov, W. & Hortobagyi, G. N., 2005, In: Journal of Clinical Oncology. 23, 25, p. 5983-5992 10 p.

Research output: Contribution to journal › Article › peer-review

374 Scopus citations

Women age < 35 years with primary breast carcinoma: Disease features at presentation

Gonzalez-Angulo, A. M., Broglio, K., Kau, S. W., Eralp, Y., Erlichman, J., Valero, V., Theriault, R., Booser, D., Buzdar, A. U., Hortobagyi, G. N. & Arun, B., Jun 15 2005, In: Cancer. 103, 12, p. 2466-2472 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

70 Scopus citations

2004

A phase I and pharmacokinetic study of TAS-108 in postmenopausal female patients with locally advanced, locally recurrent inoperable, or progressive metastatic breast cancer

Blakely, L. J., Buzdar, A., Chang, H. Y., Frye, D., Theriault, R., Valero, V., Rivera, E., Booser, D., Kuritani, J. & Tsuda, M., Aug 15 2004, In: Clinical Cancer Research. 10, 16, p. 5425-5431 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

19 Scopus citations

Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy

Pusztai, L., Mendoza, T. R., Reuben, J. M., Martinez, M. M., Willey, J. S., Lara, J., Syed, A., Fritsche, H. A., Bruera, E., Booser, D., Valero, V., Arun, B., Ibrahim, N., Rivera, E., Royce, M., Cleeland, C. S. & Hortobagyi, G. N., Feb 7 2004, In: Cytokine. 25, 3, p. 94-102 9 p.

Research output: Contribution to journal › Article › peer-review

259 Scopus citations

Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer

Ayers, M., Symmans, W. F., Stec, J., Damokosh, A. I., Clark, E., Hess, K. R., Lecocke, M., Metivier, J., Booser, D., Ibrahim, N., Valero, V., Royce, M., Arun, B., Whitman, G., Ross, J., Sneige, N., Hortobagyi, G. N., Pusztai, L. & Miller, K., Sep 2004, In: Women's Oncology Review. 4, 3, p. 211-213 3 p.

Research output: Contribution to journal › Article › peer-review

Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer

Ayers, M., Symmans, W. F., Stec, J., Damokosh, A. I., Clark, E., Hess, K., Lecocke, M., Metivier, J., Booser, D., Ibrahim, N., Valero, V., Royce, M., Arun, B., Whitman, G., Ross, J., Sneige, N., Hortobagyi, G. N. & Pusztai, L., 2004, In: Journal of Clinical Oncology. 22, 12, p. 2284-2293 10 p.

Research output: Contribution to journal › Article › peer-review

490 Scopus citations

2003

A phase III trial of sequential adjuvant chemotherapy for operable breast carcinoma: Final analysis with 10-year follow-up

Assikis, V., Buzdar, A. U., Yang, Y., Smith, T., Theriault, R., Booser, D., Valero, V., Walters, R., Singletary, E., Ames, F. & Hortobagyi, G., Jun 1 2003, In: Cancer. 97, 11, p. 2716-2723 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

17 Scopus citations

A Phase I study of docetaxel plus cyclophosphamide in solid tumors followed by a Phase II study as first-line therapy in metastatic breast cancer

Trent, J. C., Valero, V., Booser, D. J., Esparza-Guerra, L. T., Ibrahim, N., Rahman, Z., Vernillet, L., Patel, S., David, C. L., Murray, J. L., Cristofanilli, M. & Hortobagyi, G. N., Jul 1 2003, In: Clinical Cancer Research. 9, 7, p. 2426-2434 9 p.

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors

Pusztai, L., Ayers, M., Stec, J., Clark, E., Hess, K., Stivers, D., Damokosh, A., Sneige, N., Buchholz, T. A., Esteva, F. J., Arun, B., Cristofanilli, M., Booser, D., Rosales, M., Valero, V., Adams, C., Hortobagyi, G. N. & Fraser Symmans, W., Jul 1 2003, In: Clinical Cancer Research. 9, 7, p. 2406-2415 10 p.

Research output: Contribution to journal › Article › peer-review

201 Scopus citations

Daniel J Booser

Research output

Search results